PharmaCielo Q3 Revenue Stagnates, What About Adjusted EBITDA?
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX: PCLOF), released financial results for the third quarter ended September 30, 2022, revealing total revenue of CA$475,323 ($348,000), a 2% decrease compared to CA$485,165 in Q3 2021.
